United Cannabis Corp Receivables Turnover Ratio (CNAB), from the third quarter 2019 to the third quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
United Cannabis Corp  (CNAB)
 

United Cannabis Accounts Receivables Turnover Ratio from the third quarter 2019 to the third quarter 2018

Quarterly Results, Trends, Rankings, Statistics


United Cannabis Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2019 to a ratio of 89.82, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2019. Average receivable collection period, for the United Cannabis in Sep 30 2019 quarter, has decreased to 4 days, compared to 5 days, in the Jun 30 2019 quarter.

If we take a look into Healthcare sector 56 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. 733.

What is Receivable Turnover Ratio?
What is United Cannabis Corp Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CNAB Receivables Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Receivable Change -23.93 % 168.65 % -6.32 % - 191.59 %
Y / Y Revenue Change 121.55 % 112.77 % 1557.07 % - 1977.05 %
Receivable Turnover Ratio (TTM) 89.82 70.99 77.26 48.88 49.87
CNAB's Total Ranking # 733 # 733 # 736 # 155 # 733
Accounts Receivable average collection period days 4 5 5 7 7
Seq. Receivable Change -48.54 % 485.73 % -82.09 % 40.87 % 81.75 %
Seq. Revenue Change 19.25 % -10.22 % 47.86 % 39.95 % 14.53 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 16
Healthcare Sector # 57
Overall Market # 733

Receivable Turnover Ratio Statistics
High Average Low
3.57 0.89 0.08
(Mar 31 2017)   (Mar 31 2018)





CNAB Company Profile • Back to CNAB Efficiency Comparisons • Compare CNAB Receivables Turnover Ratio to its Competitors

Financial Statements
United Cannabis's Accounts Receivable $ 0 Millions Visit CNAB's Balance sheet
United Cannabis's Sales TTM $ 16 Millions Visit CNAB's Income Statement
Sources of CNAB's Revenues Visit CNAB's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CNAB's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CNAB's Growth Rates CNAB's Roa CNAB's Inventory Turnover Ratio CNAB's Dividend Comparisons
CNAB's Profitability Ratios CNAB's Roi CNAB's Asset Turnover Ratio CNAB's Dividend Growth
CNAB's Valuation Ratios CNAB's Roe CNAB's Financial Strength Ratios CNAB's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2019 Receivable at quarter ending Sep 30 2019
Arena Pharmaceuticals Inc   277.89 $ 812.077  Millions$ 2.922  Millions
Theravance Biopharma inc   256.29 $ 59.652  Millions$ 0.233  Millions
Siga Technologies Inc  176.41 $ 485.755  Millions$ 2.754  Millions
Editas Medicine Inc   162.79 $ 14.366  Millions$ 0.088  Millions
U s Stem Cell Inc   154.41 $ 4.427  Millions$ 0.029  Millions
Logicmark Inc  130.93 $ 15.747  Millions$ 0.120  Millions
Reliv International Inc  128.06 $ 36.211  Millions$ 0.283  Millions
Vystar Corporation  118.63 $ 6.509  Millions$ 0.055  Millions
Mersana Therapeutics inc   114.39 $ 43.269  Millions$ 0.378  Millions
Decoy Therapeutics Inc   112.87 $ 1.334  Millions$ 0.012  Millions
Lifevantage Corp  110.90 $ 226.577  Millions$ 2.043  Millions
Innovage Holding Corp   107.17 $ 22.719  Millions$ 0.212  Millions
Immunogen inc   100.24 $ 50.823  Millions$ 0.507  Millions
H cyte Inc  98.34 $ 6.712  Millions$ 0.068  Millions
Agenus Inc  77.86 $ 121.997  Millions$ 1.567  Millions
Athersys Inc  74.55 $ 6.859  Millions$ 0.092  Millions
Lifemd Inc   61.12 $ 10.709  Millions$ 0.175  Millions
Mimedx Group Inc   58.99 $ 315.441  Millions$ 5.347  Millions
Arvinas Inc   58.58 $ 41.523  Millions$ 0.709  Millions
Concert Pharmaceuticals Inc   57.44 $ 1.077  Millions$ 0.019  Millions
Scorpius Holdings inc   55.93 $ 3.108  Millions$ 0.056  Millions
Ayala Pharmaceuticals Inc   54.92 $ 20.884  Millions$ 0.380  Millions
U S Physical Therapy Inc  54.28 $ 477.204  Millions$ 8.791  Millions
Bicycle Therapeutics Plc  53.39 $ 0.614  Millions$ 0.012  Millions
Axim Biotechnologies Inc   52.57 $ 0.680  Millions$ 0.013  Millions
Nuo Therapeutics Inc   48.19 $ 0.953  Millions$ 0.020  Millions
Nanomix Corp  47.08 $ 0.020  Millions$ 0.000  Millions
Nature s Sunshine Products inc   45.67 $ 367.894  Millions$ 8.056  Millions
Sonida Senior Living Inc   44.74 $ 453.510  Millions$ 10.136  Millions
Biocorrx Inc   44.03 $ 0.229  Millions$ 0.005  Millions

Date modified: 2026-09-12T06:21:14+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.